BMC Microbiology                                                                                                                         BioMed Central



Research article                                                                                                                       Open Access authentic methionine aminopeptidase genes differentially expressed Bacillus subtilis
CongHui 1,2, HongYan Luâ€ 3, Agnieszka Sekowska*4, Gang Fang2,
YiPing Wang1, Anne-Marie Gilles*2 Antoine Danchin2

Address: 1National Laboratory Protein Engineering Plant Genetic Engineering, College Life Sciences, Peking University, 100871,
Beijing, P.R. China, 2Institut Pasteur, UnitÃ© GÃ©nÃ©tique des GÃ©nomes BactÃ©riens, 28 rue du Docteur Roux, 75724 Paris Cedex 15, France, 3HKU-
Pasteur Research Centre, Dexter H. C. Man Building, 8 Sassoon Road Pokfulam, Hong Kong, S R., P.R. China 4CEA Saclay, Laboratoire Stress
Oxydants et Cancer, DSV/DBJC/SBMS, Bat 142, 91191 Gif sur Yvette Cedex, France
Email: CongHui - cyou@pasteur.fr; HongYan Lu - lv_hongyan@hotmail.com; Agnieszka Sekowska* - AS208663@dsvidf.cea.fr;
Gang Fang - fangg@pasteur.fr; YiPing Wang - wangyp@pku.edu.cn; Anne-Marie Gilles* - amgilles@pasteur.fr;
Antoine Danchin - adanchin@pasteur.fr
* Corresponding authors â€ Equal contributors




Published: 05 October 2005                                                    Received: 01 August 2005
                                                                              Accepted: 05 October 2005
BMC Microbiology 2005, 5:57   doi:10.1186/1471-2180-5-57 article available  http://www.biomedcentral.com/1471-2180/5/57
Â© 2005 et al; licensee BioMed Central  Open Access article distributed terms Creative Commons Attribution License (http://creativecommons.org/licenses 2.0), permits unrestricted use, distribution, reproduction medium, provided original work properly cited.




                 Abstract
                 Background: putative methionine aminopeptidase genes, map (essential) yflG (non-
                 essential), identified genome sequence Bacillus subtilis. investigated                  function methionine aminopeptidases explored possible reasons                  essentiality dispensability B. subtilis.
                 Results: silico analysis MAP evolution uncovered coordinated pattern MAP                  deformylase did correlate pattern 16S RNA evolution. Biochemical assays
                 showed MAP (MAP_Bs) YflG (YflG_Bs) B. subtilis overproduced Escherichia
                 coli obtained pure proteins exhibited methionine aminopeptidase activity vitro.
                 Compared MAP_Bs, YflG_Bs approximately orders magnitude efficient
                 assayed synthetic peptide substrates. map yflG genes expressed multi-copy
                 plasmids complement function defective map gene chromosomes E.
                 coli B. subtilis. contrast, lacZ gene transcriptional fusions showed promoter activity
                 map 50 100-fold higher yflG. Primer extension analysis detected                  transcription start site yflG promoter. work identified YvoA acted possible
                 weak repressor yflG expression B. subtilis vivo.
                 Conclusion: MAP_Bs YflG_Bs functional methionine aminopeptidases vitro                  vivo. high expression level map low expression level yflG account                  essentiality dispensality B. subtilis, respectively, cells grown laboratory
                 conditions. difference activity synthetic substrates suggests different
                 protein targets vivo.




                                                                                                                                       Page 1 15
                                                                                                                 (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                  http://www.biomedcentral.com/1471-2180/5/57




Background                                                      codes methionine aminopeptidase. attempt Ribosome-mediated protein synthesis initiated         better understand functional role MAP, studied methionine  eukaryotes) N-formylme-           evolutionary trend MAPs silico demonstrated
thionine  prokaryotes eukaryotic organelles) [1].        map yflG genes B. subtilis code  removal N-formyl group           methionine aminopeptidases vitro vivo; 
polypeptide peptide deformylase (DEF, EC 3.5.1.88),           finding high expression level map par- N-terminal methionine large number proteins         allel low expression yflG B. subtilis, cleaved methionine aminopeptidase (MAP, EC                account essentiality dispensability,
3.4.11.18) [2,3]. efficiency removal initiator    respectively.
methionine defined highly conserved local sub-
strate specificity, determined methionine      Results adjacent residue. MAP hydrolytically removes        Sequence alignment evolutionary pattern analyses
N-terminal methionine penultimate resi-           genome sequence B. subtilis, genes bears small uncharged chain (Gly, Ala, Ser,      code methionine aminopeptidases, map yflG,
Thr, Pro, Val, Cys) [4-9], residues downstream        respectively [21] (Figure 1). sequence similarity penultimate residue little impact reaction.     identity E. coli MAP (MAP_Ec) B. subtilis MAPs studied date reported cobalt-            MAP (MAP_Bs) 65  46 , respectively. Similarity
dependent metalloproteases [3].  reports           MAP_Ec YflG B. subtilis (YflG_Bs) showed MAPs exhibited activity presence          55  identity 34  similarity divalent ions, Zn(II), Fe(II) Mn(II) [10-      MAP_Bs YflG_Bs 58  identity 36 .
12]. According sequence homology, MAPs              sequence YflG_Bs differs slightly grouped subtypes, type type II [13,14].       PROSITE consensus type MAPs (PS00680), insertion approximately 60 residues C-terminal        [MFY]-x-G-H-G- [LIVMC]-[GSH]-x(3)-H-x(4)-[LIVM]-x-
domain type II methionine aminopeptidases             [HN]-[YWVH]. particular displays extra residue difference types [14]. Eukaryotes          conserved GHG metal-binding motif. 
possess map genes, type type II      ingly, MAP_Bs similar MAP_Ec YflG_Bs [3], map gene prokaryotic       similar putative methionine ami-
genomes, type (Archaea) type II (Bacteria) [15].    nopeptidase Staphylococcus aureus (labelled "YMAP"
                                                                Figure 1). Overall proteins similar MAP distributed living organisms,        physico-chemical properties  closely similar
plays important physiological role. deletion      length slightly acidic).  shown Fig-
single map gene prokaryotes Escherichia coli [16]    ure 1, metal (presumably cobalt) binding site (high- Salmonella typhimurium [17] lethal. yeast, dele-   lighted residues) conserved. important
tion map genes (type type II)        investigate proteins methionine ami-
causes slow growth phenotype, deletion          nopeptidase activity.
genes lethal [18]. MAP activity essential role living cells? Previous studies showed    difference evolution proteins considered proteins needed N-terminal methio-           essential related organisms (Firmicutes) intriguing, removed normal biological activity, proper         explored evolution pattern map study
subcellular localization eventual degradation               meant identify persistent genes bacteria [23]. (reviewed [19]). result, possible MAP     matched evolution 16S RNA, map gene
essential essentiality downstream tar-    does follow linear course evolution, gets. essentiality, MAP changes dynamics         ribosomal proteins [23], shows erratic pattern (Fig- sulfur containing metabolites,            ure 2). suggests MAP involved differ-
important role homeostasis cell.                  ent biological processes role methionine
                                                                aminopeptidase according organisms. general, map gene genome         prompted explore evolution MAP pro-
prokaryotes, exception cyanobacteria strain,      teins functionally related, using criteria functional methionine aminopeptidases           used identify persistent genes. defined persistent
[20]. Surprisingly, genomes Bacilli,      genes genes present orthologs 85  putative MAP genes detected sequence             genomes clade  26 Firmicutes), alignment. B. subtilis, putative genes responsible       removing obligatory endosymbionts list  MAP activity, map yflG, identified [21].         Methods). protein divergence (sequence similarity
Kobayashi et al. [22] reported map essential gene    divided sequence length difference) MAP B. subti- B. subtilis yflG  apparent paradox yflG   lis orthologs Firmicutes compared


                                                                                                                   Page 2 15
                                                                                             (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                    http://www.biomedcentral.com/1471-2180/5/57




Figure 1 alignment MAP E. coli, B. subtilis, S. aureus
Sequences
Sequences alignment MAP E. coli, B. subtilis, S. aureus. line shows protein sequence MAP B. subtilis (MAP_Bs), second shows MAP E. coli (MAP_Ec), shows YflG B. subtilis (YflG_Bs) shows YflG/MAP Staphylococcus aureus (YMAP_Sa). Identical amino acids shadowed dark conserva-
tive amino acids shadowed grey. highlighted residues stand conserved amino acids important MAP
activity (bold italic residues conservative basic ones, bold acidic ones). [MFY]-x-G-H-G-[LIVMC]-[GSH]-
x(3)-H-x(4)-[LIVM]-x-[HN]-[YWVH]  H cobalt ligand) conserved motif protein sequences (placed alignment).



 bacterial evolutionary distance (measured 16S            molecular mass MAP_Bs YflG_Bs rRNA distance). Similar analyses performed           27409.17 Â± 0.92 Da 27209.35 Â± 2.14 Da, respectively.
general protease, ClpP, DEF, ribosomal protein S4, RpsD          Interestingly, proteins purified E. coli retained YkrB, second deformylase present B. subtilis (Fig-      initial methionine, consistent nature ure 2). Interestingly, contrast expected evolution-    second residue, isoleucine cases.
ary pattern RpsD, MAP exhibited erratic
evolutionary way Def YkrB, functional             seen Table 1, enzymes exhibited methionine
deformylases B. subtilis, suggesting evolution          aminopeptidase activity vitro synthetic peptide
methionine aminopeptidase deformylase.                       substrates tested. differed widely,                                                                   extent activity: specific activity YflG_Bs Enzyme activity vitro                                         90- 20-fold higher MAP_Bs recognized gene function identification         tetrapeptide MGMM tripeptide MAS sub-
solely based sequence comparisons mislead-           strates, respectively. enzymes preferred tetrapep-
ing [24,25].  determined map          tide MGMM substrate. MAS MG yflG authentic MAP genes overproducing           substrates, MAP_Bs activity 76.9  46.2  proteins E. coli characterizing enzymatic activ-    MGMM substrate, respectively, YflG_Bs
ity. products map yflG genes purified        retained 17.7  0.6  relative activity, respec- 90  homogeneity. Mass spectrometry showed              tively, substrates.


                                                                                                                     Page 3 15
                                                                                               (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                     http://www.biomedcentral.com/1471-2180/5/57




YkrB 2
Evolutionary
Figure         trend analyses MAP, ClpP, Def, RpsD Evolutionary trend analyses MAP, ClpP, Def, RpsD YkrB. Map, ClpP, Def, RpsD YkrB picked B. subtilis. BBHs Firmicutes detected. protein divergence (sequence similarity
divided sequence length difference) B. subtilis orthologs Firmicutes compared bacte-
rial evolutionary distance individually (measured 16S
rRNA evolution).




Table 1: Reaction rate MAP_Bs YflG_Bs different
peptides substrates

                                   Specific Activity (U/mg)

 Peptide (4 mM)                  MAP_Bs               YflG_Bs
                                                                            activity
                                                                   Figure 3of
                                                                   Relative
                                                                   present                  MAP_Bs (B) YflG_Bs                                                                                          ions
                                                                                      
                                                                              different
                                                                   Relative activity   MAP_Bs (B) YflG_Bs                                                                    present different ions. MGMM (4 mM) used  MGMM                            2.6 Â± 0.3           232.0 Â± 8.2
 MAS                             2.0 Â± 0.1            41.0 Â± 5.5
                                                                   substrate. ions tested 0.2 mM concentration.
 MG                              1.2 Â± 0.1            1.3 Â± 0.1
                                                                   relative activity defined 100                                                                     presence Co2+ (MAP_Bs: 2.6 U/mg; YflG_Bs: 232.0 U/mg).
 measurements proteins different
 substrates 


                                                                   methionine aminopeptidase located C-termi- effect divalent ions (0.2 mM) enzyme activity            nal polypeptide chain [20,26-29], N- investigated (Figure 3). MAP_Bs significant activ-         terminal GFP fusions proteins expected
ity Mn2+ Co2+. MAP_Bs retained                       interfere functions. addition, 
appreciable activity (26â€“50 ) replacement Co2+            structed C-terminal GFP fusions MAP_Bs Cd2+, Zn2+, Ca2+, Mg2+, Cu2+, Sr2+ Ba2+,          YflG_Bs, possible degradation Ni2+. contrast, YflG_Bs showed strong preference          fusion proteins vivo unknown reasons, Co2+ decrease activity 20              failed detect fluorescence case (data divalent ions tested.                                        shown). Cells strains BSIP8001 (MAP::GFP fusion)
                                                                   BSIP8002 (YflG::GFP fusion) mid-exponential
Subcellular localization                                           growth phase collected visualized fluores- investigate MAP_Bs YflG_Bs dif-             cence microscopy, respectively. GFP-MAP_Bs (Figure
ference subcellular localization, constructed N-       4A) GFP-YflG_Bs (Figure 4B) proteins distributed
terminal green fluorescent protein (GFP) fusions           evenly cells. expected, intensity proteins. previously reported, catalytic domain          fluorescence proteins increased 

                                                                                                                      Page 4 15
                                                                                                (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                   http://www.biomedcentral.com/1471-2180/5/57




Figure 4 GFP-MAP_Bs GFP-YflG_Bs fusions
Localization
Localization GFP-MAP_Bs GFP-YflG_Bs fusions.  Localization GFP-MAP_Bs strain BSIP8001 grown minimal medium 0.5  xylose (w/v); B. Localization GFP-YflG_Bs strain BSIP8002 grown minimal medium 1 
xylose (w/v).




increasing concentration xylose used induce expres-        map expression considerably higher yflG
sion GFP fusions (0.1 - 1  (w/v)) (data               expression
shown).                                                          fact map essential yflG [22],
                                                                 ability yflG gene rescue MAP_Bs
MAP-defective mutants rescued MAP_Bs YflG_Bs           function supplied high level, points substan-
supplied trans                                                tial differences expression level genes. E. coli mutant EM9 contains engineered map gene,          test possibility, expression map yflG genes expression control isopropyl Î²-D-          B. subtilis vivo studied using lacZ reporter
thiogalactoside (IPTG), strain grow           gene.
unless IPTG added growth medium [16]. Using replicative vector pBAD, holds arabinose-           Strains BSHP7042 BFS4611 grown minimal
inducible promoter, map yflG genes B.               medium used monitor expression map
subtilis individually introduced strain EM9.        yflG, respectively. map gene showed higher
shown Figure 5, transformants complement            promoter activity (Figure 6). activity increased gradu- map defect IPTG omitted (leading MAP           ally log phase growth nearly fold
deficiency) high concentration arabinose sup-        increase detected (109â€“379 U/mg) early
plied, case plasmids carrying B. subtilis map   exponential stationary growth phases. contrast, yflG genes. Lower concentrations arabinose par-       yflG gene showed low activity tially supported growth. demonstrated map         conditions tested (4â€“8 U/mg) (Figure 6). summary, yflG B. subtilis supply MAP function E.      map gene promoter showed 50 100-fold higher activity
coli vivo.                                                    yflG using lacZ reporter gene.
 B. subtilis, map essential gene, yflG      Promoter localization yflG gene
[22].  map yflG copy         B. subtilis genome, yflG gene located upstream
control IPTG provided multi-copy plasmid pDG148            yflH gene, followed putative Rho-independent
(30â€“50 copies using pUB110 replicon B. subtilis         transcription terminator. RT-PCR experiments demon-
[30]), map::lacZ disruptants chromosome B. sub-        strated yflG yflH belonged common tran-
tilis obtained (BSHP7046 BSHP7037).               scription unit, making operon (data shown).
theless, witnessed cases systematic            Furthermore, lacZ transcription fusion yflH gene
formation variegated blue white streaked colonies          (strain BSHP7043) showed activity changes X-gal plates, clones extremely unstable, leading        yflG gene conditions tested (data loss transformants generations (data       shown), substantiating RT-PCR results. order shown).                                                      identify promoter yflG-yflH operon, carried
                                                                 primer extension analysis. primers complemen-
                                                                 tary different regions inside yflG gene used
                                                                 yielding identification transcription start


                                                                                                                     Page 5 15
                                                                                               (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                  http://www.biomedcentral.com/1471-2180/5/57




                                                               Expression
                                                               Figure 6 map yflG lacZ transcriptional fusions
                                                               Expression map yflG lacZ transcriptional
                                                               fusions. Î²-galactosidase expression map yflG lacZ
                                                               transcriptional fusion growth curve strains
                                                               BSHP7042 BFS4611 minimal medium. OD600 (â??)                                                                Î²-galactosidase activity (â—?) measured strain
                                                               BSHP7042 map lacZ transcription fusion. OD600 (äŠ?)                                                                Î²-galactosidase activity (â– ) measured strain
                                                               BFS4611 yflG lacZ transcription fusion.



Figure 5rescue experiments
Genetic
Genetic rescue experiments. bacteria streaked M63 minimal solid medium plates incubated 37Â°C overnight. concentration IPTG     point correlate structure promoter 1 mM. order plates picture described        poor expression yflG conditions tested. left right   EM9
host strain M63 IPTG; EM9 M63 IPTG. B.
EM9 strain pBAD vector (ECHP1007) M63            YvoA showed slight repression effect yflG expression IPTG; ECHP1007 M63 arabinose (0.5  (W/V));        expression yflG B. subtilis vivo low,
ECHP1007 M63 IPTG arabinose. C. EM9             endeavoured uncover conditions enhance strain caring pBAD map vector (ECHP1005) M63           expression. significant difference arabinose (0.5  (W/V)); ECHP1005 M63 IPTG;             carbon, nitrogen sulfur sources changed, ECHP1005 M63 IPTG; ECHP1005 M63             difference conditions sporulation ger-
arabinose (0.02  (W/V)); ECHP1005 M63 arabinose        mination (data shown). genes proximal (0.1  (W/V)). D. EM9 strain caring pBAD yflG vector            chromosome code proteins related
(ECHP1006) M63 arabinose (0.5  (W/V));                 functions, neighbourhood yflG analysed. Gene
ECHP1006 M63 IPTG; ECHP1006 M63             nagP, encodes putative phosphoenolpyruvate-
IPTG; ECHP1006 M63 arabinose (0.1  (W/V));
                                                               dependent transport N-acetylglucosamine-specific
ECHP1006 M63 arabinose (0.02  (W/V)).
                                                               enzyme IICB component, located upstream yflG                                                                transcribed divergently (Figure 8A). share com-
                                                               mon control elements. Exploring corresponding inter-
                                                               genic region sliding window 19 nt-long                                                                uncovered sequence AATTGGTATAGATCACTAG                                                                significant counterpart (AGCTGGTCTAGAT-
point. shown Figure 7, start located 31 nt        CACTAG) upstream nagAB operon, encoding upstream ATG translation start codon regions        N-acetylglucosamine metabolic genes putative tran-
weakly similar consensus -35 (TTCCTA) -10               scriptional regulator (GntR family) gene, yvoA (Figure
(TAAGCT) regions upstream start point,       8A). prompted investigate YvoA separated 18 nt, rich region. difficult   possible regulator yflG. Using lacZ fusion, 

                                                                                                                   Page 6 15
                                                                                             (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                   http://www.biomedcentral.com/1471-2180/5/57




Figure
Identification
         7     transcription start point yflG promoter
Identification transcription start point yflG promoter. Primer extension sequencing reaction performed primer. size extended product compared DNA-sequencing ladder corre-
sponding region. arrow indicates +1 site. Predicted -10 -35 regions bold boxed; experimental tran-
scription start site bold; translational start site underlined.




monitored expression yflG yvoA-disrupted            vitro (Table 1 Figure 3). Furthermore, gene rescue
strain, BSIP8004.                                               experiments showed map yflG genes
                                                                expressed replicative plasmids supply MAP shown Figure 8B, promoter yflG showed low        function E. coli B. subtilis, demonstrating consistently higher activity yvoA gene disrupted     MAP_Bs YflG_Bs functional methionine ami-
strain BSIP8004 compared wild type par-           nopeptidases vivo (Figure 5). Interestingly, Kobayashi et
ent BFS4611  fold higher activity). suggested          al. [22] reported disruption map gene B. sub- YvoA contribute regulation yflG            tilis lethal, deletion yflG  expression.                                                     present study, obtained B. subtilis map mutants                                                                 map yflG genes expressed multi-copy replicative
Discussion                                                      plasmids control IPTG induced promoter prokaryotes, usually accepted   (strains BSHP7046 BSHP7037). observation sug-
gene responsible methionine aminopeptidase.             gests single copy yflG gene expressed  B. subtilis genome program predicted              chromosome supply MAP function B.
existence methionine aminopeptidase genes, map           subtilis, substantiating conditions yflG [21]. shown MAP_Bs               expression extremely low, making MAP signif-
YflG_Bs functional methionine aminopeptidases            icant methionine aminopeptidase available. 

                                                                                                                    Page 7 15
                                                                                              (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                    http://www.biomedcentral.com/1471-2180/5/57



                                                                 phosphate deaminase activity modulated amino-
                                                                 terminal methionine enzyme [31]. tried                                                                  growth conditions involving N-acetylglucosamine                                                                  carbon nitrogen source,  did                                                                  modulation YflG activity (data shown).                                                                  explored expression yflG::lacZ fusions sporula-
                                                                 tion germination. enhancement observed
                                                                 (data shown). consequence, surmise                                                                  high expression level map accounts essentiality                                                                  B. subtilis.

                                                                 published MAP_Ec activity [6,11] 5â€“10 times
                                                                 higher MAP_Bs assay conditions.                                                                  related observation map gene E.
                                                                 coli does belong highly expressed ribosome pro-
                                                                 tein operon, contrast situation B. subtilis [32].
                                                                 result, relative expression level map E. coli
                                                                 lower map gene B. subtilis.                                                                  unknown reasons impossible yflG
                                                                 gene function main methionine aminopeptidase
                                                                 B. subtilis vivo spite high activity YflG_Bs
                                                                 vitro. shown Table 2, enzyme activity MAPs
                                                                 crude cell extracts E. coli (BL5), B. subtilis (168)                                                                  yflG disrupted B. subtilis strain (BFS4611) showed                                                                  difference vitro condition tested.
                                                                 Different expression levels map genes genome car-
                                                                 rying methionine aminopeptidase genes
                                                                 previously suggested main reason                                                                  different physiological roles vivo, direct
                                                                 evidence            provided       [20,33].     Methionine
                                                                 aminopeptidases vivo active proteins, e.                                                                  complex polypeptides [34,35] short pep-
                                                                 tides vitro assays. specific tar-
Expression
Figure
rupted strain
         8 yflG lacZ transcriptional fusions yvoA dis-     gets require specific aminopeptidase. similar
Expression yflG lacZ transcriptional fusions yvoA          conclusion holds apparently paralogous genes.
disrupted strain.  gene organization yflG           example, functional peptide
yvoA. arrows indicate direction gene transcription;   deformylases B. subtilis, probably B. Î²-galactosidase expression yflG lacZ transcriptional fusion   predominant deformylase concomitant high gene yvoA disrupted strain BSIP8004 yvoA wild type strain      expression [36].
BFS4611 grown minimal medium. OD600 (â??) Î²-galac-
tosidase activity (â—?) measured strain BSIP8004.
OD600 (äŠ?) Î²-galactosidase activity (â– ) measured         finding evolutionary parallel trend strain BSIP8004 strain BFS4611.                          methionine aminopeptidase deformylase Firmi-
                                                                 cutes (Figure 2) consistent functional relationship
                                                                 vivo, correlates fact deformy-
                                                                 lase removes N-formyl groups prerequisite                                                                  subsequent function MAP [33]. evolution corroborated lacZ fusion studies showing         signature protein-protein interactions [37,38],
map gene expressed 50â€“100-fold higher yflG          intriguing conjecture, supported conditions tested. Despite weak expression         consistent duplication deformylases genomes yflG,  detected sigma promoter using           methionine aminopeptidase (Table
primer extension (Figure 7). showed         3).
expression modulated YvoA (Figure 8), suggesting possible connection N-acetylglucosamine                  Conclusion
metabolism methionine aminopeptidase.                proved MAP_Bs YflG_Bs functional
respect worth noting E. coli glucosamine-6-        methionine aminopeptidases B. subtilis 

                                                                                                                      Page 8 15
                                                                                                (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                                   http://www.biomedcentral.com/1471-2180/5/57



Table 2: MAP activity crude cell extracts E. coli B. subtilis

                                                                                Specific Activity (U/mg)

         Peptide (4 mM)                           E. coli (BL5)                  B. subtilis wild type (168)        B. subtilis yflG mutant (BFS4611)

              MGMM                                 1.5 Â± 0.2                             1.5 Â± 0.1                             1.5 Â± 0.1
               MAS                                 1.1 Â± 0.2                             1.1 Â± 0.1                             1.1 Â± 0.2
               MG                                  0.6 Â± 0.1                             0.8 Â± 0.2                             0.4 Â± 0.1

 Cells stationary growth phase strains collected sonically disrupted. Supernatants cell debris used  measure MAP activity. Totally, times measurements carried 



suggested map gene essential high                     experiments performed accordance expression level, yflG nonessential possibly                        European regulation requirements concerning  low expression level making                   tained use Genetically Modified Organisms Group compensate function map map                      (French agreement NÂ° 2735). expressed, specific targets dedicated MAPs. Conservation map-                       DNA techniques
like genes Bacilli suggests involvement process                      DNA purification, restriction enzyme digestion, ligation
specific group organisms, involve                       transformation E. coli performed according peptide deformylase.                                                    standard protocols [40]. cloning purpose, YieldAce                                                                              Pfu DNA polymerase (Stratagene) used. DNA
Methods                                                                      sequences plasmids constructed work Bacterial strains, plasmids, culture conditions                          determined using dideoxy-chain termination method
E. coli B. subtilis strains plasmids used             Thermo Sequenase Kit (Amersham Pharmacia
work listed Table 4. E. coli TG1 XL1-Blue                    Biotech). B. subtilis cells transformed plasmid
used cloning experiments (TG1 single cross                      DNA following steps protocol described previ-
recombination replicative plasmids propagation                        ously [41]. Transformants selected LB plates 
XL1-Blue double cross recombination) E.coli                     taining corresponding antibiotics IPTG needed.
BL5 IPTG-induced protein overproducing. B. subtilis
168 used wild type strain study. E. coli                  Plasmid strain constructions
cells grown Luria-Bertani (LB) medium [39]                     order clone genes B. subtilis protein pro-
M63 minimal medium (KH2PO4, 4.4 mM; K2HPO4, 8                                ducing E. coli, map yflG genes amplified
mM; (NH4)2SO4, 15 mM; MgSO4, 2 mM; ferric citrate, 34                        PCR genomic DNA B. subtilis 168 cloned
ÂµM; VitB1, 0.0001  (w/v); fructose, 0.4  (w/v); sodium                       expression vector pET24b(+) (Novagen) using NdeI
citrate, 0.3 mM; CaCl2, 50 ÂµM; MnCl2, 5 ÂµM; ZnCl2, 12 ÂµM;                    XhoI restriction sites. amplified fragments
CuCl2, 2.5 ÂµM; CoCl2, 2.5 ÂµM; Na2MoO4, 2.5 ÂµM)                               included nucleotides +1 +744 nucleotides +1 supplemented final concentration arabinose                         +747 relative translational start point map 0.02  0.5  (w/v) needed. B. subtilis cells                      yflG, respectively. resulting constructs, plasmids grown SP medium minimal medium                                 pIPP8003 pIPP8004, transformed E. coli
(K2HPO4, 8 mM; KH2PO4, 4,4 mM; glucose, 27 mM; Na3-                          BL5 giving strains ECIP8003 ECIP8004 overpro-
citrate, 0.3 mM; L-glutamine, 15 mM; L-tryptophan, 0.244                     ducing MAP YflG, respectively.
mM; ferric citrate, 33.5 ÂµM; MgSO4 L-methionine, 1
mM; MgCl2, 0.61 mM; CaCl2, 49.5 ÂµM; FeCl3, 49.9 ÂµM;                          construct map yflG GFP fusion plasmids MnCl2, 5.05 ÂµM; ZnCl2, 12.4 ÂµM; CuCl2, 2.52 ÂµM; CoCl2,                       strains, map yflG genes amplified PCR
2.5 ÂµM; Na2MoO4, 2.48 ÂµM). Antibiotics added                         genomic DNA B. subtilis 168 cloned N- following concentrations required: ampicillin,                      terminal GFP fusion vector pSG1729 [42] using XhoI 100 Âµg/ml; spectinomycin, 80 Âµg/ml; chloramphenicol, 5                       EcoRI restriction sites. amplified fragments included
Âµg/ml; phleomycin, 5 Âµg/ml; kanamycin, 100 Âµg/ml E.                      nucleotides +1 +744 nucleotides +1 +747
coli 5 Âµg/ml B. subtilis. IPTG added 1 mM                     relative translational start point map yflG,
concentration stated needed. Solid media                     respectively. resulting plasmids, pIPP8001 prepared adding 1.5  agar (w/v) respective liq-                    pIPP8002, linearized ScaI restriction enzyme
uid media. Bacteria grown 37Â°C. optical den-                     transformed B. subtilis 168. Clones sity (OD) bacterial cultures measured 600 nm.


                                                                                                                                        Page 9 15
                                                                                                                 (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                    http://www.biomedcentral.com/1471-2180/5/57



Table 3: Distribution def map genes selected genomes

                                                                       Numbers Genome

 Genome                                                       def                    map                        EMBL ID

 Streptomyces coelicolor                                           4                        3                        AL645882
 Streptomyces avermitilis                                          3                        4                        BA000030
 Nocardia farcinica IFM 10152                                      3                        3                        AP006618
 Shewanella oneidensis MR-1                                        3                        1                        AE014299
 Silicibacter pomeroyi DSS-3                                       3                        1                        CP000031
 Bacillus cereus ZK                                                2                        3                        CP000001
 Bacillus thuringiensis serovar konkukian                          2                        3                        AE017355
 Bacillus anthracis 'Ames Ancestor'                                2                        3                        AE017334
 Bacillus anthracis Sterne                                         2                        3                        AE017225
 Bacillus cereus ATCC 10987                                        2                        3                        AE017194
 Bacillus anthracis Ames                                           2                        3                        AE016879
 Bacillus cereus ATCC 14579                                        2                        3                        AE016877
 Leifsonia xyli subxyli CTCB07                                     2                        3                        AE016822
 Synechocystis PCC 6803                                            1                        3                        BA000022
 Bacillus clausii KSM-K16                                          1                        3                        AP006627




selected amylase deficient phenotype double        introducing SalI cloning site 5' end SphI
cross recombination amyE site [42], giving strains       cloning site 3' end, respectively. fragments
BSIP8001 BSIP8002, respectively.                             inserted SalI SphI sites IPTG-
                                                                 inducible replicative vector pDG148 [44], producing obtain map yflG expression plasmids           plasmid pHPP7021 pHPP7022, respectively. map gene rescue analysis conditional map gene dele-         wild type strain B. subtilis 168 transformed tion E. coli strain, EM9 [16], map (nucleotides -30      plasmids, giving strains BSHP7045 BSHP7038,
+744 relative map translation start point) yflG       respectively.
(nucleotides -21 +754 relative yflG translation
start point) genes amplified PCR genomic            disrupt map gene, 246 bp-long fragment DNA B. subtilis 168 creation BamHI            map gene (nucleotides +142 +388 relative BglII sites. purified PCR fragments cleaved         map translation start point) amplified PCR BamHI BglII restriction enzymes inserted                 genomic DNA B. subtilis 168 using primers introducing sites plasmid pBAD containing            EcoRI cloning site 5' end BamHI cloning
arabinose inducible promoter  modified pBAD-Î±Î²Î³                site 3' end fragment. fragment plasmid containing additional BamHI cloning site          inserted EcoRI BamHI sites plasmid
used removing BamHI BglII insert [43]), pro-         pJM783 [45], contains promoterless lacZ reporter
ducing plasmids pHPP1017 pHPP1018, respectively.             gene, producing plasmid pHPP7025. plasmid proper orientation checked ability             introduced chromosome BSHP7045 cloned fragment recovered double digestion              BSHP7038 strains single cross event, giving
using BamHI BglII restriction enzymes. Plasmids              strains BSHP7046 BSHP7037, respectively. ascer-
pHPP1017, pHPP1018 pBAD vector trans-               tain correctly inserted, clones checked
formed E. coli strain EM9 individually selected         PCR. LB plates containing ampicillin, chloramphenicol IPTG, giving strains ECHP1005, ECHP1006                      construct map transcriptional fusion lacZ
ECHP1007, respectively.                                          gene, DNA fragment downstream map gene
                                                                 (nucleotides + 423 relative translation start obtain map yflG copies          point gene's stop codon) amplified PCR
ditional map disruptant construction B. subtilis, map     genomic DNA B. subtilis 168 using primers intro-
gene (nucleotides -43 +744 relative map transla-       ducing EcoRI cloning site 5' end BamHI
tion start point) yflG gene (nucleotides -54 733 rel-     cloning site 3' end fragment, inserted
ative yflG translation start point) amplified      EcoRI BamHI sites plasmid pJM783 [45],
PCR genomic DNA B. subtilis 168 using primers            producing plasmid pHPP7017. plasmid intro-


                                                                                                                     Page 10 15
                                                                                                (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                                        http://www.biomedcentral.com/1471-2180/5/57



Table 4: Bacterial strains plasmids used created study

 Strains             Genotype                                                                                     Source Reference

 Escherichia coli

 XL1-Blue            K12 supE44 hsdR17 recA1 endA1 gyrA46 thi relA1 lac- F'[proAB+ lacIq lacZâˆ†M15 Tn10(tetR)]     Laboratory collection
 TG1                 K12 supE hsdâˆ†5 thi âˆ† (lac-proAB) F'[traD36 proA+ proB+ lacIq lacZâˆ†M15]                       Laboratory collection
 BL5(DE3)            F-                                                                                           Invitrogen
 EM9                 PT7-map  chromosome)                                                                      Chiron Culture Collection Centre
 ECIP8003            F- pIPP8003                                                                                  work
 ECIP8004            F- pIPP8004                                                                                  work
 ECHP1005            EM9 pHPP1017                                                                                 work
 ECHP1006            EM9 pHPP1018                                                                                 work
 ECHP1007            EM9 pBAD                                                                                     work

 Bacillus subtilis

 168                 trpC2                                                                                        Laboratory collection
 BFS4611             trpC2 yflG::lacZ                                                                             Functional analysis projecta
 BFS817              trpC2 yvoA::lacZ                                                                             Functional analysis projecta
 BSHP7042            trpC2 map-lacZ                                                                               work
 BSHP7045            trpC2 pDG148-map                                                                             work
 BSHP7046            trpC2 map::lacZ pDG148-map                                                                   work
 BSHP7037            trpC2 map::lacZ pDG148-yflG                                                                  work
 BSHP7038            trpC2 pDG148-yflG                                                                            work
 BSHP7043            trpC2 yflH::lacZ                                                                             work
 BSIP8001            trpC2 amyE::gfp-map                                                                          work
 BSIP8002            trpC2 amyE::gfp-yflG                                                                         work
 BSIP8003            trpC2 yvoA::[(lacZ-ery)::pEC23(Kan)]                                                         work
 BSIP8004            trpC2 yflG::lacZ yvoA::[(lacZ-ery)::pEC23(Kan)]                                              work

 Plasmids            Description                                                                                  Source Reference

 pET24b(+)           expression vector, KanR                                                                      Novagen
 pBAD-abg            genetic rescue vector, AmpR                                                                  [43]
 pDG148              expression vector, AmpR KanR                                                                 [44]
 pJM783              cloning vector, CmR                                                                          [45]
 pSG1729             N-terminal GFP fusion vector, AmpR SpecR                                                     [42]
 pEC23               integrative plasmid, KanR                                                                    M. Simon P. Stragier, unpublished
 pIPP8003            pET24b map                                                                                   work
 pIPP8004            pET24b yflG                                                                                  work
 pHPP1017            pBAD map                                                                                     work
 pHPP1018            pBAD yflG                                                                                    work
 pHPP7017            pJM783 map-lacZ                                                                              work
 pHPP7018            pJM783 yflH::lacZ                                                                            work
 pHPP7021            pDG148 map                                                                                   work
 pHPP7022            pDG148 yflG                                                                                  work
 pHPP7025            pJM783 map::lacZ                                                                             work
 pIPP8001            pSG1729 map                                                                                  work
 pIPP8002            pSG1729 yflG                                                                                 work

   strain constructed frame project functional characterization genome B. subtilis Japan [46].



duced chromosome B. subtilis 168 single                          nese project functional analysis genome crossover event, giving strain BSHP7042.                                          B. subtilis, 2000 genes dis-
                                                                                  rupted fusion lacZ reporter gene [22,46,47]. yflG transcriptional fusion lacZ gene
(yflG::lacZ disruptant, strain BFS4611) constructed                           construct yflH transcriptional fusion lacZ framework European Union Japa-                              gene, DNA fragment downstream yflH gene


                                                                                                                                           Page 11 15
                                                                                                                      (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                 http://www.biomedcentral.com/1471-2180/5/57



(nucleotides + 32 +310 relative translation     o-dianisidine dihydrochloride 0.1 M Tris-HCl (pH
start point) amplified PCR genomic DNA          7.4)), tube incubated 37Â°C 10 min, B. subtilis 168 using primers introducing EcoRI cloning     absorbance 440 nm recorded. Standard curve site 5' end BamHI cloning site 3' end   known concentration L-methionine colour fragment, inserted EcoRI BamHI sites     development buffer plotted quantitative analysis. plasmid pJM783 [45], producing plasmid pHPP7018.            absorbance 1 Âµmol methionine ml 440 plasmid introduced chromosome B.           nm equivalent 8.6 [6]. Unit activity subtilis 168 single cross event, giving strain       defined 1 Âµmol methionine produced min BSHP7043.                                                      assay conditions used. Preference metal ions                                                                tested changing cobalt substrate solution obtain disruptant yvoA strain compatible           divalent metal ions final concentration BFS4611, BFS817 strain (yvoA::lacZ disruptant,        0.2 mM. European Union Japanese consortium,  transformed ScaI linearized pEC23 plasmid         Amylase activity detected growth B. subtilis
 carries kanamycin resistance gene, M. Simon       strains Tryptose Blood Agar Base (TBAB, Difco) supple-
P. Stragier, unpublished) replacement kan-        mented 10 g/l hydrolyzed starch (Sigma). Starch
amycin resistance gene lacZ Erm genes belong-       degradation detected sublimating iodine ing pMutin plasmid (erythromycin resistant)             plates [49].
integrated genome, homologous recombina-
tion. resulting clones checked inability    Î²-galactosidase specific activity measured described grow erythromycin chloramphenicol.               Miller [50]. Unit Î²-galactosidase activity resulting strain named BSIP8003. chromosomal           defined enzyme produced 1 nmol
DNA BSIP8003 prepared used transform         o-nitrophenol min 28Â°C. Specific activity BFS4611 strain, producing double yvoA yflG dis-        expressed Units mg protein. experiments rupted strain BSIP8004.                                        performed triplicates.

Expression purification MAP_BS YflG_Bs              Subcellular localization analysis
proteins                                                       visualize GFP-MAP_Bs GFP-YflG_Bs fusions loca- strains ECIP8003 ECIP8004 grown 37Â°C           tions living cells, BSIP8001 BSIP8002 strains LB medium containing kanamycin (25 Âµg/ml)               grown minimal medium 0.5  fructose sole
induced 0.5 mM IPTG hours. Cell pellets          carbon source supplemented xylose different final harvested centrifugation stored -20Â°C.          concentrations (0.1  1  (w/v)). Cells mid-
Cells suspended 20 mM Tris-HCl (pH 8.0)            exponential growth phase collected visualized
sonically disrupted. cellular debris removed        fluorescence microscopy. Microscope Axiovert 135 TV
centrifugation 12,000 g 40 min. supernatants        (ZEISS, Germany) used experiment fluo- applied DEAE-sephacel column chromatogra-            rescence filter sets used visualize GFP obtained
phy (Amersham). protein (MAP_Bs YflG_Bs)            Chroma Technology Corp (USA). Cells visual-
eluted 0.1 M NaCl buffer. Protein         ized 1  agarose (w/v) slides [51] using Axiovision 4
centration determined Bradford's method [48]        (Allied High Tech Products, ) exposure
using protein assay kit (Bio-Rad Laboratories). purity     time 3â€“10 s. isolated proteins determined SDS-PAGE [40].
Ion mass spectrometry used measure molecular        Genetic rescue experiment
mass purified protein checking exist-   growth EM9, ECHP1005 (containing B. subtilis map
ence methionine proteins.          gene), ECHP1006 (containing B. subtilis yflG gene)                                                                ECHP1007 (containing pBAD vector , Enzyme assays                                                  compared M63 minimal medium plates (37Â°C,  methionine aminopeptidase assay performed           night) presence absence IPTG (1 mM) described Arie Ben-Bassat et al. [6] small modifi-     arabinose (0.02  , 0.1   0.5  ).
cations. 10 Âµl protein solution added 90 Âµl substrate solution (4 mM peptide 0.1 M K2HPO4               RNA isolation manipulation
(pH7.5), 0.2 mM CoCl2), incubated 37Â°C         Total cellular RNA extracted B. subtilis 168 cells
10 min. reaction stopped incubation 100Â°C        growing minimal medium OD600 0.5 using 2 min. addition 900 Âµl colour              High Pure RNA Isolation Kit Roche. RNA 
development mixture (containing 0.2 mg L-amino acid         centration determined light absorption 260 nm
oxidase, 0.03 mg horseradish peroxidase, 0.2 mg      280 nm. 2 Âµg RNA loaded 1.2  agarose


                                                                                                                 Page 12 15
                                                                                            (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                     http://www.biomedcentral.com/1471-2180/5/57



gel check RNA purity integrity. RT-PCR experi-      enzyme activity analysis, helped draft manu-
ments performed using RT-PCR (Promega)             script. AD designed supervised study. specified manufacturer.
                                                               Acknowledgements
Primer extension analysis carried using reverse        initial stage work supported HKU-Pasteur Research
transcriptase AMV (Roche) described [52]. oligo-        Centre (SAR Hong Kong, China) like thank HF Kung nucleotides (+33 +62 +97 +126 relative trans-     KY Yuen early moment. CH supported
                                                               EGIDE (France). like thank JD Huang kind gift lation start point yflG) used identification
                                                               pBAD-Î±Î²Î³ vector, Chiron Culture Collection Center conditional map yflG promoter. primers used gen-      gene deletion E. coli mutant, EM9, U Mechold kind suggestions eration sequence ladders. Reaction products            experiment manuscript drafting, YL Yap contribution sil-
separated 7  denaturing polyacrylamide gel contain-         ico analyses discussion.
ing 8 M urea. DNA sequences determined using
Sanger's dideoxy chain-termination method                 References
"Thermo Sequenase radiolabeled terminator cycle                1.    Kozak M: Comparison initiation protein synthesis pro-
                                                                     caryotes, eucaryotes, organelles. Microbiol Rev 1983,
sequencing kit" Amersham Pharmacia Biotech.                     47:1-45.
                                                               2.    Link AJ, Robison K, Church GM: Comparing predicted DNA sequence silico analysis                                  observed properties proteins encoded genome                                                                      Escherichia coli K-12. Electrophoresis 1997, 18:1259-1313.
DNA sequences analyzed using DNA Strider soft-        3.    Bradshaw RA, Brickey WW, Walker KW: N-terminal processing:
ware [53]. program BLAST [54] used search             methionine aminopeptidase N alpha-acetyl trans-
homologous sequences database. program                    ferase families. Trends Biochem Sci 1998, 23:263-267.
                                                               4.    Huang S, Elliott RC, Liu PS, Koduri RK, Weickmann JL, Lee JH, Blair
CLUSTALW used multiple alignment [55]. B. sub-               LC, Ghosh-Dastidar P, Bradshaw RA, Bryan KM: Specificity tilis sequences analyzed using SubtiList database           cotranslational amino-terminal processing proteins                                                                      yeast. Biochemistry 1987, 26:8242-8246.
[56,57]. Accepted consensus sequences extracted           5.    Moerschell RP, Hosokawa Y, Tsunasawa S, Sherman F: specifi- PROSITE [58,59].                                                cities yeast methionine aminopeptidase acetylation                                                                      amino-terminal methionine vivo. Processing altered
                                                                     iso-1-cytochromes         c    created           oligonucleotide
Evolutionary pattern analyses                                        transformation. J Biol Chem 1990, 265:19638-19643.  MAP orthologs (orthologs defined using         6.    Ben-Bassat  Bauer K, Chang SY, Myambo K, Boosman  Chang S:
                                                                     Processing initiation methionine proteins: prop-
BBH (Bi-directional Best Hit) strategy, e. gene            erties Escherichia coli methionine aminopeptidase
genome similar hit gene b genome B               gene structure. J Bacteriol 1987, 169:751-757. vice versa, gene b regarded pair         7.    Tsunasawa S, Stewart JW, Sherman F: Amino-terminal processing
                                                                     mutant forms yeast iso-1-cytochrome c. specifici-
orthologs [60]) retrieved pair bacte-           ties methionine aminopeptidase acetyltransferase. J
rial genomes. Secondly, BBHs, protein sequence              Biol Chem 1985, 260:5382-5391.
similarity >50  protein length difference <1.3,     8.    Miller CG, Strauch KL, Kukral  Miller JL, Wingfield PT, Mazzei GJ,
                                                                     Werlen RC, Graber P, Movva NR: N-terminal methionine-spe-
gene map B. subtilis collected. Thirdly,                 cific peptidase Salmonella typhimurium. Proc Natl Acad Sci U
orthologs BBHs collected              S 1987, 84:2718-2722.
                                                               9.    Hirel PH, Schmitter MJ, Dessen P, Fayat G, Blanquet S: Extent N-
genomes  total 206 bacterial genomes EMBL              terminal methionine excision Escherichia coli proteins
July 1st, 2005), recursive identification            governed chain length penultimate
members cluster longer extended.              amino acid. Proc Natl Acad Sci U S 1989, 86:8247-8251.
                                                               10.   Walker KW, Bradshaw RA: Yeast methionine aminopeptidase protein divergence (sequence similarity divided                   utilize Zn2+ Co2+ cofactor: case mis-
sequence length difference) MAP B. subtilis            taken identity? Protein Sci 1998, 7:2684-2687.
orthologs Firmicutes compared bac-        11.   D'Souza V M, Holz RC: methionyl aminopeptidase                                                                      Escherichia coli function iron(II) enzyme. Biochem-
terial evolutionary distance (measured 16S rRNA                   istry 1999, 38:11079-11085.
evolution). analyses carried ClpP, Def,       12.   Wang J, Sheppard GS, Lou P, Kawai M, Park C, Egan DA, Schneider
                                                                      Bouska J, Lesniewski R, Henkin J: Physiologically relevant
RpsD YkrB.                                                       metal cofactor methionine aminopeptidase-2                                                                      manganese. Biochemistry 2003, 42:5035-5042.
Authors' contributions                                         13.   Bazan JF, Weaver LH, Roderick SL, Huber R, Matthews BW:
                                                                     Sequence structure comparison suggest methio-
CHY carried MAPs enzyme activity analysis, subcellu-             aminopeptidase, prolidase, aminopeptidase P, crea-
lar observation, expression level comparisons, drafted           tinase share common fold. Proc Natl Acad Sci U S 1994,
                                                                     91:2473-2477. manuscript. HYL did genetic rescue experiment E.        14.   Arfin SM, Kendall RL, Hall L, Weaver LH, Stewart AE, Matthews BW,
coli primer extension analysis. designed initial          Bradshaw RA: Eukaryotic methionyl aminopeptidases: experiments, completed genetic rescue experiment              classes cobalt-dependent enzymes. Proc Natl Acad Sci U S                                                                      1995, 92:7714-7718.
B. subtilis, constructed lacZ fusion mutants B. subtilis,   15.   Li JY, Cui YM, Chen LL, Gu M, Li J, Nan FJ, Ye QZ: Mutations wrote manuscript. GF did evolutionary            S1 sites methionine aminopeptidases Escherichia
pattern analyses. YPW helped analyse experimental             coli Homo sapiens reveal residues critical sub-
                                                                     strate specificity. J Biol Chem 2004, 279:21128-21134.
data draft manuscript. AMG supervised MAPs


                                                                                                                         Page 13 15
                                                                                                    (page number citation purposes)
 BMC Microbiology 2005, 5:57                                                                         http://www.biomedcentral.com/1471-2180/5/57



16.   Chang SY, McGary EC, Chang S: Methionine aminopeptidase                      27.   Liu S, Widom J, Kemp CW, Crews CM, Clardy J: Structure       gene Escherichia coli essential cell growth. J Bacteriol                 human methionine aminopeptidase-2 complexed       1989, 171:4071-4072.                                                               fumagillin. Science 1998, 282:1324-1327.
17.   Miller CG, Kukral  Miller JL, Movva NR: pepM essential              28.   Griffith EC, Su  Turk  Chen S, Chang YH, Wu  Biemann K, Liu
      gene Salmonella typhimurium.                         J Bacteriol 1989,          JO: Methionine aminopeptidase (type 2) common
      171:5215-5217.                                                                     target angiogenesis inhibitors AGM-1470 ovalicin.
18.   Li X, Chang YH: Amino-terminal protein processing Saccha-                       Chem Biol 1997, 4:461-471.
      romyces cerevisiae essential function requires                29.   Zuo S, Guo Q, Ling C, Chang YH: Evidence zinc fingers
      distinct methionine aminopeptidases. Proc Natl Acad Sci U S                      methionine aminopeptidase Saccharomyces cer-
      1995, 92:12357-12361.                                                              evisiae important normal growth. Mol Gen Genet 1995,
19.   Lowther WT, Matthews BW: Structure function                             246:247-253.
      methionine aminopeptidases.                 Biochim Biophys Acta 2000,       30.   McKenzie T, Hoshino T, Tanaka T, Sueoka N: nucleotide
      1477:157-167.                                                                      sequence pUB110: salient features relation 20.   Atanassova  Sugita M, Sugiura M, Pajpanova T, Ivanov  Molecular                replication regulation. Plasmid 1986, 15:93-103.
      cloning, expression characterization distinctive                31.   Lara-Gonzalez S, Dixon HB, Mendoza-Hernandez G, Altamirano MM,
      genes encoding methionine aminopeptidases cyanobacte-                           Calcagno ML: role N-terminal group allos-
      rium Synechocystis sp. strain PCC6803. Arch Microbiol 2003,                        teric function glucosamine-6-phosphate deaminase       180:185-193.                                                                       Escherichia coli. J Mol Biol 2000, 301:219-227.
21.   Kunst F, Ogasawara N, Moszer  Albertini  Alloni G, Azevedo V,           32.   Suh JW, Boylan SA, Oh SH, Price CW: Genetic transcrip-
      Bertero MG, Bessieres P, Bolotin  Borchert S, Borriss R, Boursier                tional organization Bacillus subtilis spc-alpha region.
      L, Brans  Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV,                 Gene 1996, 169:17-23.
      Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton              33.   Giglione C, Serero  Pierre M, Boisson B, Meinnel T: Identification
       Cummings NJ, Daniel RA, Denizot F, Devine KM, Dusterhoft                     eukaryotic peptide deformylases reveals universality N-
      Ehrlich SD, Emmerson PT, Entian KD, Errington J, Fabret C, Ferrari E,              terminal protein processing mechanisms. Embo J 2000,
      Foulger D, Fritz C, Fujita M, Fujita Y, Fuma S, Galizzi  Galleron N,             19:5916-5929.
      Ghim SY, Glaser P, Goffeau  Golightly EJ, Grandi G, Guiseppi G,            34.   Palmiter RD, Gagnon J, Walsh KA: Ovalbumin: secreted pro-
      Guy BJ, Haga K, Haiech J, Harwood CR, Henaut  Hilbert H, Holsap-                 tein transient hydrophobic leader sequence. Proc
      pel S, Hosono S, Hullo MF, Itaya M, Jones L, Joris B, Karamata D, Kasa-            Natl Acad Sci U S 1978, 75:94-98.
      hara Y, KlaerrBlanchard M, Klein C, Kobayashi Y, Koetter P,                  35.   Jackson R, Hunter T: Role methionine initiation hae-
      Koningstein G, Krogh S, Kumano M, Kurita K, Lapidus  Lardinois S,                moglobin synthesis. Nature 1970, 227:672-676.
      Lauber J, Lazarevic V, Lee SM, Levine  Liu H, Masuda S, Mauel C,           36.   Haas M, Beyer D, Gahlmann R, Freiberg C: YkrB main pep-
      Medigue C, Medina N, Mellado RP, Mizuno M, Moestl D, Nakai S,                      tide deformylase Bacillus subtilis, eubacterium contain-
      Noback M, D, OReilly M, Ogawa K, Ogiwara  Oudega B,                        ing functional peptide deformylases. Microbiology 2001,
      Park SH, Parro V, Pohl TM, Portetelle D, Porwollik S, Prescott                  147:1783-1791.
      Presecan E, Pujic P, Purnelle B, Rapoport G, Rey M, Reynolds S, Rieger       37.   Goh CS, Cohen FE: evolutionary analysis reveals insights
      M, Rivolta C, Rocha E, Roche B, Rose M, Sadaie Y, Sato T, Scanlan E,               protein-protein interactions. J Mol Biol 2002, 324:177-192.
      Schleich S, Schroeter R, Scoffone F, Sekiguchi J, Sekowska  Seror SJ,      38.   Ramani AK, Marcotte EM: Exploiting evolution inter-
      Serror P, Shin BS, Soldo B, Sorokin  Tacconi E, Takagi T, Takahashi              acting proteins discover interaction specificity. J Mol Biol
      H, Takemaru K, Takeuchi M, Tamakoshi  Tanaka T, Terpstra P,                      2003, 327:273-284.
      Tognoni  Tosato V, Uchiyama S, Vandenbol M, Vannier F, Vassarotti          39.   Bertani G: Studies lysogenesis.  mode phage liber-
       Viari  Wambutt R, Wedler E, Wedler H, Weitzenegger T, Win-                    ation lysogenic Escherichia coli. J Bacteriol 1951, 62:293-300.
      ters P, Wipat  Yamamoto H, Yamane K, Yasumoto K, Yata K, Yosh-             40.   Sambrook J FEGMT: Molecular Cloning: Laboratory Manual.
      ida K, Yoshikawa HF, Zumstein E, Yoshikawa H, Danchin                        NY, Cold Spring Harbor; 1989.
      complete genome sequence Gram-positive bacterium                      41.   Kunst F, Rapoport G: Salt stress environmental signal
      Bacillus subtilis. Nature 1997, 390:249-256.                                       affecting degradative enzyme synthesis Bacillus subtilis. J
22.   Kobayashi K, Ehrlich SD, Albertini  Amati G, Andersen KK, Arnaud                 Bacteriol 1995, 177:2403-2407.
      M, Asai K, Ashikaga S, Aymerich S, Bessieres P, Boland F, Brignell SC,       42.   Lewis PJ, Marston AL: GFP vectors controlled expression
      Bron S, Bunai K, Chapuis J, Christiansen LC, Danchin  Debarbouille               dual labelling protein fusions Bacillus subtilis. Gene
      M, Dervyn E, Deuerling E, Devine K, Devine SK, Dreesen O, Err-                     1999, 227:101-110.
      ington J, Fillinger S, Foster SJ, Fujita Y, Galizzi  Gardan R, Eschevins   43.   Muyrers JP, Zhang Y, Testa G, Stewart AF: Rapid modification       C, Fukushima T, Haga K, Harwood CR, Hecker M, Hosoya D, Hullo                      bacterial artificial chromosomes ET-recombination.
      MF, Kakeshita H, Karamata D, Kasahara Y, Kawamura F, Koga K,                       Nucleic Acids Res 1999, 27:1555-1557.
      Koski P, Kuwana R, Imamura D, Ishimaru M, Ishikawa S, Ishio  Le            44.   Stragier P, Bonamy C, Karmazyn-Campelli C: Processing       Coq D, Masson  Mauel C, Meima R, Mellado RP, Moir  Moriya S,                   sporulation sigma factor Bacillus subtilis: morpholog-
      Nagakawa E, Nanamiya H, Nakai S, Nygaard P, Ogura M, Ohanan T,                     ical structure control gene expression. Cell 1988,
      O'Reilly M, O'Rourke M, Pragai  Pooley HM, Rapoport G, Rawlins                   52:697-704.
      JP, Rivas LA, Rivolta C, Sadaie  Sadaie Y, Sarvas M, Sato T, Saxild        45.   Perego M: Integrational vectors genetic manipulation       HH, Scanlan E, Schumann W, Seegers JF, Sekiguchi J, Sekowska                     Bacillus subtilis. Bacillus subtilis Gram-positive bacteria
      Seror SJ, Simon M, Stragier P, Studer R, Takamatsu H, Tanaka T,                    Edited  Sonenshein AL HJALR. Washington, D.C, Amercian Society
      Takeuchi M, Thomaides HB, Vagner V, van Dijl JM, Watabe K, Wipat                   Microbiology; 1993:615-624.
       Yamamoto H, Yamamoto M, Yamamoto Y, Yamane K, Yata K,                     46.   Bacillus Subtilis Genome Database                          [http://bacil
      Yoshida K, Yoshikawa H, Zuber U, Ogasawara N: Essential Bacillus                   lus.genome.ad.jp]
      subtilis genes. Proc Natl Acad Sci U S 2003, 100:4678-4683.                47.   Micado Release 6.1 [http://locus.jouy.inra.fr/cgi-bin/genmic/mad
23.   Fang G, Rocha E, Danchin  essential non-essential                        base/progs/madbase.operl]
      genes? Mol Biol Evol, press .                                             48.   Bradford MM: rapid sensitive method quantita-
24.   Brenner SE: Errors genome annotation. Trends Genet 1999,                        tion microgram quantities protein utilizing princi-
      15:132-133.                                             